Press Releases Lee's Pharmaceutical Holdings Limited

Equities

950 KYG5438W1116

Market Closed - Hong Kong S.E. Other stock markets 04:08:08 2024-06-04 am EDT			5-day change	1st Jan Change
1.2 ^HKD	-3.23%		+2.56%	-21.57%

Apr. 19	Lee’s Pharmaceutical's 2023 Profit Slumps 67%	MT
Mar. 26	Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sorrento Therapeutics' License Partner, Lee's Pharm, Announces Full Enrollment of 498 Patients in a Phase III Trial of Socazolimab (Anti-PD-L1 Antibody) for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)	22-05-18	AQ
Listing on Guidance for Family Choice Pharmacy of Lee's Pharm signature products, Ferplex and Yallaferon	21-12-31	AQ
Sorrento’s License Partner, Lee’s Pharmaceutical Announces NDA Filing Acceptance by NMPA for Anti-PD-L1 Antibody Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer	21-11-01	AQ
Lee Pharmaceutical : Notice of Board Meeting	21-05-14	PU
Lee Pharmaceutical : (1) Establishment of Management Committee; (2) Resignation of Chief Executive Officer and Re-designation of Director; and (3) Change of Authorised Representative	21-04-28	PU
Lee Pharmaceutical : List of Directors and their Role and Function	21-04-28	PU
Lee Pharmaceutical : Terms of Reference of the Management Committee	21-04-28	PU
Lee Pharmaceutical : Connected Transaction - Provision of Financial Assistance	21-04-28	PU
Lee Pharmaceutical : Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Final Offer Price	21-04-28	PU
Lee Pharmaceutical : General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, and Notice of Annual General Meeting	21-04-21	PU
Lee Pharmaceutical : Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Publication of The Prospectus and Expected Size of The Global Offering and Offer Price Range	21-04-15	PU
Lee Pharmaceutical : Voluntary Announcement - Update on Research and Development of an Investigational Ophthalmology Product of an Associated Company of the Group	21-04-12	PU
Lee Pharmaceutical : Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Post Hearing Information Pack	21-04-06	PU
Lee Pharmaceutical : Connected Transaction - Provision of Financial Assistance	21-03-26	PU
Lee Pharmaceutical : Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Record Date, Closure of Register of Members and Basis of The Assured Entitlement of Qualifying Shareholders in The Preferential Offering	21-03-23	PU
Lee Pharmaceutical : Extraordinary General Meeting Held on 15 March 2021 - Poll Results	21-03-15	PU
Lee Pharmaceutical : Voluntary Announcement - Update on an Investigational Direct Oral Anticoagulant	21-03-11	PU
Lee Pharmaceutical : Voluntary Announcement - Update on an Investigational Ophthalmology Product of an Associated Company of the Group	21-03-11	PU
Sorrento Therapeutics : Lee's Pharmaceutical announces its Anti-PD-L1 Antibody Socazolimab, Licensed from Sorrento Therapeutics, receives Clearance to Start Phase 3 Trial as a First-line Treatment of Extensive-stage Small-Cell Lung Cancer	21-03-08	AQ
Lee Pharmaceutical : Voluntary Announcement - Socazolimab Obtained Approval for a Phase III Clinical Trial from NMPA	21-03-05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Lee's Pharmaceutical Holdings Limited

Equities

950

KYG5438W1116

Press Releases

Filters